Phase
Condition
N/ATreatment
PK Papyrus Covered Coronary Stent System
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with acute perforations of native coronary arteries and coronary bypassgrafts in vessels 2.5 to 5.0 mm in diameter
Exclusion
Exclusion Criteria:
Patients in whom antiplatelet agents or anticoagulation therapy is contraindicated.
Patients with a known allergy or hypersensitivity to amorphous silicon carbide orany other compound of the system (siloxane-based polyurethane, L-605 cobalt chromiumalloy including tungsten and nickel).
Lesions that cannot be reached or treated with the system.
Lesions with threatened or abrupt closure during attempted pre-dilation prior tostent implantation.
Risk of treatment-related occlusion of vital coronary artery side branches.
Uncorrected bleeding disorders.
Allergy to contrast media.
Study Design
Study Description
Connect with a study center
Methodist Dallas Medical Center
Dallas, Texas 75201
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.